# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Cervical intraepithelial neoplasia

Cervical dysplasia
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 63 results.
Performance, Safety, and Efficacy of a New Cryotherapy Device for Cervical Dysplasia [Part II]
Status: Recruiting
Last Changed: Nov 06, 2019
First Received: Nov 06, 2019
Disease(s): Cervical Dysplasia
Intervention(s): CryoPop
Locations: JN Medical College, Belgaum, Karnataka, India
Efficacy and Safety of Cevira® in Patients With Cervical Histologic High-grade Squamous Intraepithelial Lesions (HSIL)
Status: Not yet recruiting
Last Changed: Jul 23, 2020
First Received: Jul 23, 2020
Disease(s): Cervical Intraepithelial Neoplasia Grade 2/3
Intervention(s): Cevira®, Placebo
Lugol's Solution in Addition to Acetic Acid During Colposcopy
Status: Recruiting
Last Changed: Jun 04, 2020
First Received: Jun 04, 2020
Disease(s): Uterine Cervical Dysplasia
Intervention(s): acetic acid test, Lugol's solution test
Locations: Zydolab - Institute of Cytology and Immune Cytochemistry, Dortmund, NRW, Germany
Department of Obstetrics and Gynecology of the Ruhr University Bochum, Herne, NRW, Germany
HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
Status: Not yet recruiting
Last Changed: Jul 14, 2020
First Received: Oct 18, 2019
Disease(s): Human Papillomavirus Type 16, Cervical Intraepithelial Neoplasia Grade II, Cervical Intraepithelial Neoplasia, Grade III
Intervention(s): pNGVL4aCRTE6E7L2
Locations: Johns Hopkins University, Baltimore, Maryland, United States
Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3)
Status: Recruiting
Last Changed: Jun 09, 2020
First Received: Aug 11, 2016
Disease(s): Cervical Intraepithelial Neoplasia, Cervical Dysplasia
Intervention(s): 9-valent HPV vaccine, Imiquimod
Locations: Smilow Cancer Hospital at Yale New Haven, New Haven, Connecticut, United States
LLETZ With Videocolposcopy Versus LLETZ With Binocular Colposcopy
Status: Recruiting
Last Changed: Mar 31, 2020
First Received: Mar 30, 2020
Disease(s): Uterine Cervical Dysplasia
Intervention(s): LLETZ with videocolposcope, LLETZ with binocular colposcope
Locations: Department of Obstetrics and Gynecology of the Ruhr University Bochum, Herne, NRW, Germany
A Clinical Trial of PepCan to Two Therapy Arms for Treating Cervical High-Grade Squamous Intraepithelial Lesions
Status: Recruiting
Last Changed: Feb 28, 2020
First Received: Jun 25, 2015
Disease(s): Cervical Intraepithelial Neoplasia
Intervention(s): Pepcan+Candin, Candin
Locations: University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
See and Treat in an Outpatient Setting in Women Above 45 Years With Cervical Dysplasia
Status: Recruiting
Last Changed: Mar 06, 2020
First Received: Mar 06, 2020
Disease(s): Cervical Dysplasia, Cervical Lesion, Cervix Disease
Intervention(s): Cone biopsy
Locations: Horsens Regional Hospital, Horsens, Jutland, Denmark
Randers Regional Hospital, Randers, Jutland, Denmark
Viborg Regional Hospital, Viborg, Jutland, Denmark
HPV Integration Testing for Human Papillomavirus-Positive Women
Status: Recruiting
Last Changed: Jun 27, 2017
First Received: Oct 15, 2015
Disease(s): Cervical Intraepithelial Neoplasia, Cervical Cancer
Intervention(s): TCT,HPV,colposcopic inspection
Locations: Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)
Status: Recruiting
Last Changed: Feb 26, 2020
First Received: May 31, 2018
Disease(s): Cervical Cancer
Intervention(s): Colli-Pee, Qvintip
Locations: university of Antwerp - centre for the evaluation of vaccination, Wilrijk, Antwerp, Belgium